Mirae Asset Global Investments’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Sell
7,642
-824
-10% -$28.8K ﹤0.01% 1065
2026
Q1
$326K Buy
8,466
+1,007
+14% +$37.2K ﹤0.01% 1003
2025
Q4
$265K Buy
7,459
+2,058
+38% +$57.9K ﹤0.01% 1106
2025
Q3
$77.6K Buy
5,401
+1,003
+23% +$11.9K ﹤0.01% 1266
2025
Q2
$31.6K Buy
4,398
+588
+15% +$3.26K ﹤0.01% 1325
2025
Q1
$24.7K Buy
3,810
+129
+4% +$1.01K ﹤0.01% 1365
2024
Q4
$28.5K Sell
3,681
-278
-7% -$2.77K ﹤0.01% 1367
2024
Q3
$43.2K Buy
3,959
+1,104
+39% +$10.7K ﹤0.01% 1329
2024
Q2
$24.1K Sell
2,855
-49,524
-95% -$376K ﹤0.01% 1355
2024
Q1
$446K Buy
52,379
+3,912
+8% +$24.2K ﹤0.01% 1951
2023
Q4
$285K Buy
48,467
+12,293
+34% +$94.2K ﹤0.01% 2219
2023
Q3
$353K Sell
36,174
-482
-1% -$5.72K ﹤0.01% 2062
2023
Q2
$432K Sell
36,656
-2,242
-6% -$25.7K ﹤0.01% 2008
2023
Q1
$420K Buy
38,898
+9,130
+31% +$117K ﹤0.01% 2012
2022
Q4
$344K Buy
29,768
+6,801
+30% +$84.3K ﹤0.01% 2084
2022
Q3
$342K Buy
22,967
+11,354
+98% +$156K ﹤0.01% 2099
2022
Q2
$105K Buy
+11,613
New +$79.3K ﹤0.01% 2300

Other funds holding COGT

Mirae Asset Global Investments's COGT Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Cogent Biosciences (COGT) stake by 9.7% in Q2 2026, selling an estimated $28.8K and leaving 7,642 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

Mirae Asset Global Investments first reported a position in COGT in Q2 2022 and has held it in 17 quarters since. The position peaked at $446K in Q1 2024. 96 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Mirae Asset Global Investments held 7,642 shares of Cogent Biosciences worth $296K as of Q2 2026.
  • Mirae Asset Global Investments sold 824 Cogent Biosciences shares in Q2 2026, an estimated $28.8K.
  • Cogent Biosciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1065 holding.
  • Mirae Asset Global Investments first reported a position in Cogent Biosciences in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Cogent Biosciences position peaked at $446K in Q1 2024.
  • 96 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.